www.fdanews.com/articles/85017-life-sciences-are-luring-venture-capital
LIFE SCIENCES ARE LURING VENTURE CAPITAL
March 3, 2006
A healthy increase in venture- capital funding of medical-device companies has
helped lift overall investments in life-sciences industries, even as biotechnology
deals have tailed off. Companies that make artificial joints, heart stents and
other devices are attracting VC dollars because investors see rising demand
for such products as the U.S. population ages and people live longer. An active
mergers-and-acquisitions market among device companies — including Boston Scientific's
pending $27 billion purchase of Guidant — also has fueled VC interest in the
sector.
The Star-Ledger